Skip to content
★ Sign in to follow
CK

Christopher K. Murray

Vice-Président Senior des Opérations Techniques
Total declarations
22
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€1.7M

Latest filing published 11 Mar 2024 for Blueprint Medicines Corp, €210k.

Filing timeline

BuySale
Christopher K. Murray

Insider track record

Disclosed buys
0
Disclosed sells
15

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Christopher K. Murray: trading record in brief

All filings by Christopher K. Murray on record concern Blueprint Medicines Corp, in the capacity of senior executive. The record holds 22 filings, for trades running from 1 March 2020 to 7 March 2024.

No open-market purchase appears, only 15 sales worth €1.7M. Outside the open market, there are 5 share grants and 2 option exercises. Since January 2024: no purchases and 3 sales on the market.

On 11 March 2024 came the latest disclosure, an open-market sale for €210k in Blueprint Medicines Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Christopher K. Murray

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations